×
Prostate specific membrane antigen (PSMA) expression gives prostate cancer cells a growth advantage in a physiologically relevant folate environment in vitro.
Missing: Metallopeptidase; Naaladase| Binding| Enzyme- Anchor|
People also ask
The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.
Missing: Metallopeptidase; | Show results with:Metallopeptidase;
Dec 1, 2021 · In this study, molecular interactions of prostate-specific membrane antigen (PSMA) with five chemically distinct urea-based boron-containing ...
This same enzyme has been referred to as folate hydrolase (FolH1) for its ability to cleave sequentially C-terminal glutamate residues from folate polyglutamate ...
Abstract. Prostate-specific membrane antigen (PSMA) is a metallopeptidase expressed predominantly in prostate cancer (PCa) cells. PSMA is considered a biomarker ...
Prostate-specific membrane antigen (PSMA) or folate hydrolase 1 (FOLH1) is highly expressed on prostate cancer. Its expression correlates inversely with ...
Missing: Metallopeptidase; | Show results with:Metallopeptidase;
[NOTE: PSMA is different from prostate specific antigen, PSA, which is a term used for kallikrein-related peptidase 3, Chapter 609]. Historically ...
Jul 30, 2017 · Glutamate carboxypeptidase II (GCPII), also known as prostate-specific membrane antigen (PSMA) or folate hydrolase, is a metallopeptidase ...
Membrane‐bound glutamate carboxypeptidase II (GCPII) is a zinc metalloenzyme that catalyzes the hydrolysis of the neurotransmitter ...
Glutamate carboxypeptidase II (GCPII), also known as N-acetyl-L-aspartyl-L-glutamate peptidase I (NAALADase I), NAAG peptidase, or prostate-specific membrane ...
Missing: Anchor| | Show results with:Anchor|